ETF DAILY NEWS

Legend Biotech (NASDAQ:LEGN) Price Target Raised to $75.00

Legend Biotech (NASDAQ:LEGN – Free Report) had its target price hoisted by HC Wainwright from $73.00 to $75.00 in a report released on Wednesday morning, MarketBeat reports. The firm currently has a buy rating on the stock. HC Wainwright also issued estimates for Legend Biotech’s Q4 2025 earnings at $0.11 EPS. LEGN has been the […]

Mar 15, 2025 - 08:15
 0
Legend Biotech (NASDAQ:LEGN) Price Target Raised to $75.00
Legend Biotech (NASDAQ:LEGN – Free Report) had its target price hoisted by HC Wainwright from $73.00 to $75.00 in a report released on Wednesday morning, MarketBeat reports. The firm currently has a buy rating on the stock. HC Wainwright also issued estimates for Legend Biotech’s Q4 2025 earnings at $0.11 EPS. LEGN has been the […]
Read More

Tags:

Previous Article

Select Water Solutions, Inc. (NYSE:WTTR) Shares Sold by Bank of New York Mellon ...

Next Article

Adobe (NASDAQ:ADBE) Given New $540.00 Price Target at JPMorgan Chase & Co.

Related Posts

Match Group, Inc. (NASDAQ:MTCH) Receives Average Recommendation of “Hold” from Analysts

Match Group, Inc. (NASDAQ:MTCH) Receives Average Recomm...

Mar 14, 2025  0

Prothena (NASDAQ:PRTA) Given New $110.00 Price Target at Piper Sandler

Prothena (NASDAQ:PRTA) Given New $110.00 Price Target a...

Mar 1, 2025  0

PDS Biotechnology’s (PDSB) “Buy” Rating Reaffirmed at HC Wainwright

PDS Biotechnology’s (PDSB) “Buy” Rating Reaffirmed at H...

Feb 25, 2025  0